Bio Key International Inc
BKYI· Nasdaq
Released Aug 14, 2024, after the close
10-Q filed Aug 14, 2024, 45 days after period end · 0001437749-24-026861
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Revenue | $1.14M | $1.93M | $1.95M | $992.09K |
| Net Income | -$1.67M | -$2.48M | -$1.72M | -$1.16M |
| EPS Diluted | — |
Bio Key International Inc · CIK 1019034 · Engraved from SEC EDGAR
| — |
| — |
| -$0.15 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.